Doctor Désirée Deandreis

Désirée Deandreis is a nuclear medicine physician, chief of the nuclear medicine division at Gustave Roussy since 2023 and Associate Professor at University of Turin since 2016. 

Previously she served as chief of nuclear medicine division at AOU Città della Salute e della Scienza of Turin (Italy) from 2019 to 2022 and director of residency program of nuclear medicine at University of Turin from 2016 to 2022.  

From 2006 and 2016, she spent 10 years as nuclear medicine physician at Gustave Roussy with appraisal of the application of diagnostic and therapeutic nuclear medicine mainly in the field of endocrine tumors and prostate cancer. Furthermore, she spent 1 year at Memorial Sloan Kettering Cancer center in New York as visiting investigator.

Since several years, her clinical and research activity is focused on the theranostic approach in nuclear medicine and oncology, through the application of molecular imaging with diagnostic PET tracers as true “biomarkers” to improve knowledge of tumoral biology, to select the best treatment choice including radioligand therapy and application of advanced images analysis by artificial intelligence.

Principal investigator and co-principal investigator in several clinical trials, she is author of more than 140 original articles and active member of Committee and Educational program of European Association of Nuclear Medicine.